In-house IP roundup: UK Actavis ruling raises clarity on dosage regimen patents; how businesses get software patents; Google and Avon reveal portfolio management strategies

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

In-house IP roundup: UK Actavis ruling raises clarity on dosage regimen patents; how businesses get software patents; Google and Avon reveal portfolio management strategies

Money

Managing IP rounds up the latest news and analysis from patent-focused businesses

Drugs

UK Actavis ruling raises clarity on dosage regimen patents, say drug companies

Innovator and generics businesses say that the UK Supreme Court’s ruling in Actavis v Icos and the guidelines it produced give them greater insight into whether a dosage regimen would be considered obvious. Read more ...









Drugs

How businesses get software patents

Counsel at Amadeus, IBM, a tech company and a bank reveal how they give themselves the best chance of getting software patent protection through better communication with engineers and storytelling with patent examiners. Read more ... 











Google

Google and Avon: ask hard questions to get the most out of your portfolios

Senior patent counsel at one of the world’s biggest makeup companies and a tech giant delve into their sometimes cut-throat tactics for shaping their patent portfolios and the cost-saving drivers behind them. Read more ... 











Money

Blockchain: patent counsel reveal approaches to decentralised ledgers

In-house lawyers from Citigroup, Nevro and Etsy share their thoughts on blockchain strategies and how registrations might be disrupted by eligibility issues. Read more ... 









Sign up to receive more content like this in Patent Strategy’s weekly newsletter.



more from across site and SHARED ros bottom lb

More from across our site

The firm has brought in former Weil IP leaders Doug Lumish and Jeff Homrig as it looks to deepen its patent, trade secrets and ITC bench
Bird & Bird helps GSK score a major injunction as the battle to become the UPC’s busiest division tightens, and overall filings reach a new monthly high
CEO Annette Bach explains how the Danish IP consultancy plans to build on its 65% profit growth while keeping external investment off the table for now
Belgian attorneys have revived fax systems to protect clients’ filing rights, while uncertainty over exposed patent data has left firms struggling to answer questions about the breach
In his first interview since leaving Weil Gotshal & Manges, Chris Henry explains why he returned to Latham and how he plans to bolster its tech disputes offering
As GTA VI underlines the extraordinary value of gaming franchises, lawyers at Clifford Chance say investors need to know the IP behind their next deal can deliver the growth they are paying for
As ‘big law’ invests in IP litigation, trial firms are emerging as a valuable source of seasoned courtroom talent
Six hires across the IP spectrum reflect Orrick’s efforts to better serve tech clients across the IP lifecycle
David Stone, partner at White & Case, argues that the government’s planned reforms will modernise and futureproof UK design law, but leave two of the thorniest problems unresolved
Max Scott will join the firm’s IP transactions group in California, becoming the latest Weil IP partner to secure their future
Gift this article